Natural history of CNS relapse in aggressive non-Hodgkin's lymphoma: What have we learned?

Journal of Clinical Oncology

Volumn 27, Issue 21, 2009, Pages

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; RITUXIMAB;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; LETTER; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; CENTRAL NERVOUS SYSTEM; NOTE; PATHOLOGY; RECURRENT DISEASE;

CENTRAL NERVOUS SYSTEM; HUMANS; LYMPHOMA, NON-HODGKIN; RECURRENCE;

EID: 70249144715     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.0608     Document Type: Letter

References (8)

1. Bernstein SH, Unger JM, LeBlanc M, et al: Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: A 20 year follow up analysis of SWOG 8516 - The Southwest Oncology Group. J Clin Oncol 27:114-119, 2009
2. McMillan A: Central nervous system-directed preventative therapy in adults. Br J Haematol 131:13-21, 2005
3. Hollender A, Kvaloy S, Lote K, et al: Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic CNS involvement: A single center analysis. Eur J Cancer 36:1762-1768, 2000
4. van Besien K, Ha CS, Murphy S, et al: Risk factors, treatment, and outcome of CNS recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 91:1178-1184, 1998
5. Haioun C, Besson, Lepage E, et al: Incidence and risk factors of CNS relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal CNS prophylaxis: A GELA study of 974 patients. Ann Oncol 11:685-690, 2000
6. Feugier P, Virion JM, Tilly H, et al: Incidence and risk factors for CNS occurrence in elderly patients with diffuse large B-cell lymphoma: Influence of rituximab. Ann Oncol 15:129-133, 2004
7. Hegde U, Filie A, Little RF, et al: High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for CNS involvement: The role for flow cytometry versus cytology. Blood 105:496-502, 2005
8. Gleissner B, Chamberlain MC: Lymphomatous meningitis in systemic NHL. J Neurooncol 84:310-321, 2007